AVTR241122P28000
- 0.00
- 0.000.00%
Avantor Newsroom
Nvidia Partners With Quantum-Si To Advance Single-Molecule Analysis
Avantor to Participate in the 7th Annual Evercore ISI HealthCONx Conference
Express News | Quantum-Si Inc - Agreement Expands Access to Proteomics Technology in U.S. and Canada
Avantor to Distribute Quantum-Si's Next-Generation Protein Sequencing Technology
Express News | Avantor to Distribute Quantum-Si’s Next-Generation Protein Sequencing™ Technology
Quality Cyclicals Are Expected to Continue Going Up, Here Are the Top-rated by Morgan Stanley
Life Sciences Stocks Viewed Positively at TD Cowen Despite Post-election Weakness
Express News | Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science's Biggest Challenges
Avantor Opens New Bridgewater Innovation Center Focused on Solving Life Science's Biggest Challenges
Why Avantor, Inc. (NYSE:AVTR) Could Be Worth Watching
How Is The Market Feeling About Avantor?
Express News | Avantor® Appoints Dame Louise Makin, Dbe, Ph.d., to Its Board of Directors
Press Release: Avantor(R) Appoints Dame Louise Makin, DBE, Ph.D., to Its Board of Directors
Avantor's Stock Declines Despite Q3 Earnings Beat, Margins Down
Express News | Wells Fargo & Co lowers Avantor's target price from $30.00 to $28.00.
Wells Fargo Maintains Overweight on Avantor, Lowers Price Target to $28
Morgan Stanley Maintains Avantor(AVTR.US) With Buy Rating, Maintains Target Price $27
A Quick Look at Today's Ratings for Avantor(AVTR.US), With a Forecast Between $25 to $28
Avantor's Attractive Valuation and Decreasing Leverage Support Buy Rating
Forecasting The Future: 5 Analyst Projections For Avantor